
    
      The objective of this multi-center study is to optimize the long-term treatment of patients
      with first episode schizophrenia. This investigation should contribute to the issue of
      effective relapse prevention in first-episode patients. 1-year maintenance neuroleptic
      treatment is done with low dose haloperidol or risperidone (target dose 2-4 mg/die).
    
  